|
MechanismTRPV1 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Purdue Pharma, Inc.
0 Patents (Medical) associated with Purdue Pharma, Inc.
100 Deals associated with Purdue Pharma, Inc.
100 Translational Medicine associated with Purdue Pharma, Inc.